Projects per year
Personal profile
Expertise related to UN SDGs
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
Walcheck, B., Geller, M. A., Miller, J. S., Moriarity, B. S., Rendahl, A., Starr, T. & Wu, J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/1/21 → 3/31/26
Project: Research project
-
IL-15 superagonist ALT 803 maintenance therapy to prevent recurrence of advanced stage ovarian cancer
8/1/20 → 7/31/21
Project: Research project
-
Manipulating the ovarian cancer tumor microenvironment to enhance natural killer (NK) cell killing
7/1/20 → 6/30/23
Project: Research project
-
The role of cytomegalovirus and inflammation on patient symptoms and outcomes in ovarian cancer
7/1/19 → 6/30/23
Project: Research project
-
Research output
-
Cytomegalovirus and systemic inflammation at time of surgery is associated with worse outcomes in serous ovarian cancer
Wesley, E., Uppendahl, L. D., Felices, M., Dahl, C., Messelt, A., Boylan, K. L. M., Skubitz, A. P. N., Vogel, R. I., Nelson, H. H. & Geller, M. A., Jan 2021, In: Gynecologic oncology. 160, 1, p. 193-198 6 p.Research output: Contribution to journal › Article › peer-review
-
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics
Boylan, K. L. M., Afiuni-Zadeh, S., Geller, M. A., Argenta, P. A., Griffin, T. J. & Skubitz, A. P. N., Jan 7 2021, In: Clinical Proteomics. 18, 1, 4.Research output: Contribution to journal › Article › peer-review
Open Access -
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C. L., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K. & Moriarity, B. S., Jan 8 2020, In: Molecular Therapy. 28, 1Research output: Contribution to journal › Article › peer-review
17 Scopus citations -
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
Aapro, M., Bossi, P., Dasari, A., Fallowfield, L., Gascón, P., Geller, M., Jordan, K., Kim, J., Martin, K. & Porzig, S., Oct 2020, In: Supportive Care in Cancer. 28, 10, p. 4589-4612 24 p.Research output: Contribution to journal › Review article › peer-review
Open Access8 Scopus citations -
Immobilization rapidly selects for chemoresistant ovarian cancer cells with enhanced ability to enter dormancy
Lam, T., Aguirre-Ghiso, J. A., Geller, M. A., Aksan, A. & Azarin, S. M., Oct 2020, In: Biotechnology and bioengineering. 117, 10, p. 3066-3080 15 p.Research output: Contribution to journal › Article › peer-review